Ujjval Jauhari: Latest News, Top News, Photos, Videos by Ujjval Jauhari

Ujjval Jauhari

The company continues to beat the Indian pharma market growth that is likely to have grown 10.3% y-o-y.

Firm domestic growth, export prospects keep street positive on Ipca Laboratories

2 min read . Updated: 16 Apr 2021

Biocon’s prospects look good, but Street eyes better execution

1 min read . Updated: 15 Apr 2021

The fresh order comes after Fortis Healthcare and Fortis Hospitals made representation to Sebi. Photo: Pradeep Gaur/Mint

Fortis Health's prospects healthy on improved hospitals, diagnostics biz outlook

1 min read . Updated: 14 Apr 2021

Agri-input firms set for strong Q4, input costs need watching

2 min read . Updated: 14 Apr 2021

RDIF and Dr Reddy’s in 2020 had signed an agreement to collaborate on clinical trial and distribution of Sputnik V vaccine in India. (REUTERS)

Dr Reddy’s gets a Sputnik boost, but there's lack of clarity on quantum of gains

1 min read . Updated: 13 Apr 2021

Among the key growth drivers, according to analysts, was the pricing that added 5.1% to the growth in March 2021. The new product launches and volume growth also helped. (Mint)

Pharma growth hits double digits, sustenance holds key

1 min read . Updated: 13 Apr 2021

Photo: Bloomberg

Robust sales, price hikes to drive earnings of steel companies

2 min read . Updated: 11 Apr 2021

Investors are piling into FAANG shorts as US stocks continue to breach new records, with the Nasdaq Composite Index surging above 8,000 for the first time Tuesday.

Improved business prospects drive Tata Chemicals' stock but valuations pricey

1 min read . Updated: 09 Apr 2021

Photo: Sonu Mehta/Hindustan Times

Diagnostic firms’ valuations get pricey amid health fears

1 min read . Updated: 09 Apr 2021

Sebi has imposed a penalty of Rs25 crore on Mukesh Ambani, and others, for non-compliance of takeover norms in a two-decade-old share issue in the company. (File Photo: Reuters)

Reliance Industries shares shrug off Sebi fine on Mukesh Ambani

2 min read . Updated: 08 Apr 2021

Photo: Bloomberg

Low and stable gas prices result in huge gains for IGL, MGL

2 min read . Updated: 07 Apr 2021

Adani Ports shares scaled fresh highs on Wednesday.

Acquisitions lift Adani Ports stock but debt needs to be managed well

2 min read . Updated: 07 Apr 2021

Photo: Mint (Aniruddha Chowdhury/Mint)

Rising steel volumes, price hikes are driving NMDC to fresh highs

2 min read . Updated: 06 Apr 2021

Zydus Cadila is seeking approval for its hepatitis drug Pegylated Interferon for treating covid, after promising interim results from Phase III clinical trials. (Representative Image: AFP)

Cadila Healthcare: Street eyeing new covid drug approval, vaccine launch

1 min read . Updated: 06 Apr 2021

Glenmark remains one of the few companies in the pharma arena with slight concerns on debt

Improved cash flow, debt reduction crucial for Glenmark Pharma

2 min read . Updated: 05 Apr 2021

Armed with such positive cues, the company continues to focus on market share gains both in the PV and CV segments,. Photo: Mint

Firm domestic, JLR prospects to keep Tata Motors in focus

1 min read . Updated: 05 Apr 2021

SAIL’s volumes, deleveraging give its investors a boost of confidence

2 min read . Updated: 04 Apr 2021

Analysts believe that consumer sentiments in the PV segment remain positive due to a preference for personal mobility. (Mint)

Maruti Suzuki, Tata Motors, M&M impress with firm PV sales, CV sales recovery

2 min read . Updated: 02 Apr 2021

On the positive side, domestic production is expected to rise by 2% during FY22, which should support volume growth, analysts say

Unchanged natural gas prices could keep ONGC, OIL earnings in check

2 min read . Updated: 01 Apr 2021

Piramal Pharma Solutions will invest part of the funds into new plants to support the current pipeline of approximately 80 late-stage programmes. Photo: AFP (AFP)

Piramal Enterprises adds peptides segment to it its growth armoury

1 min read . Updated: 01 Apr 2021

My Reads Redeem a Gift Card Logout